The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVIDKelly Sealey
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis
National COVID-19 trends, September 1National COVID-19 trends, September 1Betsy Ladyzhets
Research updates, September 1Research updates, September 1Miles W. Griffis

Policy & Advocacy

Science

  • November 28, 2023

    What’s happening this week, November 28

  • girl in pink shirt and black pants walking on gray concrete pathway
    November 21, 2023

    Census change would reduce estimates of disability in U.S., impacting community resources and Long Covid research

  • November 21, 2023

    What’s happening this week, November 21

  • November 14, 2023

    What’s happening this week, November 14

Previous Page
1 … 36 37 38

Covid-19

Health

Commentary

  • November 28, 2025

    You know someone with Long COVID. They need you to ask about it genuinely.

  • A graphic featuring a photo of the Long COVID Treatment Trial testing kit: a package, colored teal on the inside, that includes a Garmin device, smart scale, and other supplies for the trial, along with instructions. The kit is shown three times, with a background that is light orange with white spots
    October 30, 2025

    We need more at-home clinical trials for Long COVID. Here’s how we designed the largest one yet.

  • October 10, 2025

    Vyvgart brought us back to life, but the Long COVID trial was canceled. We are calling on the NIH and HHS to study the drug.

  • October 3, 2025

    Long COVID inspired me to start an IACC case competition at my business school. Here’s how you can get involved.

Previous Page
1 … 7 8 9 10 11 … 27
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...